LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$10.48
-0.26 (-2.42%)
▼
5d:
-3.85%
30d:
-8.31%
90d:
+38.44%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 4.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 4.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.04
5.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $10.48, which is considered fair relative to its 30-day fair value range of $10.16 to $11.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.7) compared to its historical average (23.3). At these levels, the market is pricing in 4.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is currently testing key support at $10.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is currently testing key support at $10.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.16 -
$11.31
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($12.00)
- NEUTRAL: Market pricing in 4.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$10.16 -
$11.31
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.47
Resistance Level
$11.76
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.73
Wall Street Target
$12.00
(+14.5%)
Revenue Growth (YoY)
21.2%
Earnings Growth (YoY)
1927.5%
Profit Margin
1.6%
Valuation Premium vs History
+4.6% premium
PE vs Historical
26.7 vs 23.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.6%
(market-implied from PE analysis)
1-Year Target
$10.96
(+5%)
2-Year Target
$11.47
(+9%)
3-Year Target
$11.99
(+14%)
3-Yr Target (if PE normalizes)
(PE: 27→23)
PE COMPRESSION
$10.45
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.7, Growth: 25.8%)
$20.89
(+99%)
Base:
(SPY PE: 20.7, Growth: 25.8%)
$16.19
(+55%)
Bear:
(PE: 17.6, Growth: 25.8%)
$13.77
(+31%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (72x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Forward PE: 72.46 | Forward EPS (Implied): $0.14
Bull Case
$12.65
(+21%)
Analyst growth 15.0%, PE expands to 76.1
Base Case
$10.48
(0%)
Market implied 0.0%, PE stable at 72.5
Bear Case
$8.02
(-24%)
Severe decline -15.0%, PE contracts to 65.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:58 PM ET
Data refreshes hourly during market hours. Next update: 3:58 PM
Data refreshes hourly during market hours. Next update: 3:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Darren M Black
SELL
4314939 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
